Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4176
VanEck IG Floating Rate ETF
FLTR
$3.06B
| $3.52M | ﹤0.01% |
+139,226
| New | +$3.52M |
|
4177
CALL
Tenable Holdings
TENB
$3.95B
| $3.51M | ﹤0.01% |
67,200
+9,000
| +15% | +$357K |
|
4178
CALL
ProShares Ultra Gold
UGL
$817M
| $3.5M | ﹤0.01% |
205,600
+24,800
| +14% | +$416K |
|
4179
CALL
Unisys
UIS
$205M
| $3.5M | ﹤0.01% |
178,100
+142,200
| +396% | +$2.04M |
|
4180
CALL
Ericsson
ERIC
$33.4B
| $3.5M | ﹤0.01% |
293,200
+15,300
| +6% | +$179K |
|
4181
CALL
Vicor
VICR
$11.6B
| $3.5M | ﹤0.01% |
38,000
-17,000
| -31% | -$1.43M |
|
|
VXRT
4182
CALL
DELISTED
Vaxart
VXRT
| $3.5M | ﹤0.01% |
613,100
+156,400
| +34% | +$995K |
|
4183
CALL
Ichor Holdings
ICHR
$2.71B
| $3.5M | ﹤0.01% |
116,100
+88,500
| +321% | +$2.5M |
|
4184
CALL
Abercrombie & Fitch
ANF
$4.7B
| $3.5M | ﹤0.01% |
171,700
-159,800
| -48% | -$2.93M |
|
|
FAZ
4185
CALL
Direxion Daily Financial Bear 3x ETF
FAZ
$87.2M
| $3.5M | ﹤0.01% |
6,042
+869
| +17% | +$738K |
|
|
SRCL
4186
PUT
DELISTED
Stericycle Inc
SRCL
| $3.49M | ﹤0.01% |
50,400
+7,200
| +17% | +$493K |
|
4187
iShares US Regional Banks ETF
IAT
$689M
| $3.49M | ﹤0.01% |
77,048
+8,188
| +12% | +$330K |
|
|
CHIX
4188
DELISTED
Global X MSCI China Financials ETF
CHIX
| $3.49M | ﹤0.01% |
226,690
+46,627
| +26% | +$708K |
|
4189
Kulicke & Soffa
KLIC
$5.29B
| $3.49M | ﹤0.01% |
109,764
+72,692
| +196% | +$2.12M |
|
4190
American Century Focused Dynamic Growth ETF
FDG
$428M
| $3.49M | ﹤0.01% |
46,880
+9,046
| +24% | +$623K |
|
4191
PUT
Exelon
EXC
$46.8B
| $3.49M | ﹤0.01% |
115,805
-23,273
| -17% | -$687K |
|
|
XIFR
4192
PUT
XPLR Infrastructure LP
XIFR
$1.09B
| $3.49M | ﹤0.01% |
52,000
+29,300
| +129% | +$1.89M |
|
4193
PUT
West Pharmaceutical
WST
$24.6B
| $3.48M | ﹤0.01% |
12,300
+7,400
| +151% | +$2.08M |
|
4194
iShares Global Timber & Forestry ETF
WOOD
$265M
| $3.48M | ﹤0.01% |
43,762
+24,302
| +125% | +$1.73M |
|
4195
CALL
Vanguard FTSE Europe ETF
VGK
$31B
| $3.48M | ﹤0.01% |
57,800
+33,100
| +134% | +$1.86M |
|
4196
Essent Group
ESNT
$6.19B
| $3.48M | ﹤0.01% |
+80,548
| New | +$3.48M |
|
4197
CALL
ProShares UltraShort QQQ
QID
$246M
| $3.48M | ﹤0.01% |
24,505
+4,035
| +20% | +$670K |
|
4198
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.3B
| $3.48M | ﹤0.01% |
48,174
-46,838
| -49% | -$3.12M |
|
4199
PUT
Beam Therapeutics
BEAM
$2.79B
| $3.48M | ﹤0.01% |
+42,600
| New | +$2.09M |
|
4200
B2Gold
BTG
$6.9B
| $3.48M | ﹤0.01% |
620,910
-768,292
| -55% | -$4.69M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.